Shares more than doubled in value after Phase 3 results suggested Alumis’ pill may compare favorably with other emerging oral ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

Dermatologists explain how to dry brush and the benefits of using one. Shop the best dry brushes for smooth skin from brands ...

By focusing on the one mole that does not match the rest, doctors are improving early melanoma detection while avoiding ...

Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...

MESA, ARIZONA / ACCESS Newswire / January 5, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) announced today that the Company has successfully completed its internal readiness testing phase for ...

Oregon Medical Research Center in Portland, Oregon, has led a phase 2 trial in moderate-to-severe plaque psoriasis that ...

Vixarelimab showed rapid, sustained itch reduction and good safety in prurigo nodularis. Learn more about the study and ...

Repair the Skin Barrier. Yoo advises using a rich hand moisturizer with ingredients like glycerin, ceramides, shea butter, or ...

Modeling suggests large spot picosecond laser treatment can cut required fluence for dermal pigmented lesions in Asian skin and may lower collateral energy deposition, with early 1064 nm case support.